Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 5, 2010, Pages 790-797

  Sprangers, Ben ^a   Lefkowitz, George Ian ^a   Cohen, Scott D ^a   Stokes, Michael Barry ^a   Valeri, Antony ^a   Appel, Gerald B ^a   Kunis, Cheryl L ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; GRAFT DYSFUNCTION; GRAFT FAILURE; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PROTEINURIA; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL; BIOPSY; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952308415     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04120609     Document Type: Article

References (23)

1. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347: 103-109, 2002 (Pubitemid 34753480)
2. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P: Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am J Kidney Dis 35: 157-165, 2000
3. Cattran D: Management of membranous nephropathy: When and what for treatment. J Am Soc Nephrol 16: 1188-1194, 2005 (Pubitemid 41716503)
4. Cosyns JP, Couchoud C, Pouteil-Noble C, Squifflet JP, Pirson Y: Recurrence of membranous nephropathy after renal transplantation: Probability, outcome and risk factors. Clin Nephrol 50: 144-153, 1998 (Pubitemid 28434742)
5. Poduval RD, Josephson MA, Javaid B: Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. Semin Nephrol 23: 392-399, 2003 (Pubitemid 37022043)
6. Monga G, Mazzucco G, Basolo B, Quaranta S, Motta M, Segoloni G, Amoroso A: Membranous glomerulonephritis (MGN) in transplanted kidneys: Morphologic investigation on 256 renal allografts. Mod Pathol 6: 249-258, 1993
7. Truong L, Gelfand J, D'Agati V, Tomaszewski J, Appel G, Hardy M, Pirani CL: De novo membranous glomerulonephropathy in renal allografts: A report of ten cases and review of the literature. Am J Kidney Dis 14: 131-144, 1989 (Pubitemid 19218251)
8. Berger BE, Vincenti F, Biava C, Amend WJ Jr, Feduska N, Salvatierra O Jr: De novo and recurrent membranous glomerulopathy following kidney transplantation. Transplantation 35: 315-319, 1983 (Pubitemid 13117458)
9. Morzycka M, Croker BP Jr, Siegler HF, Tisher CC: Evaluation of recurrent glomerulonephritis in kidney allografts. Am J Med 72: 588-598, 1982 (Pubitemid 12089333)
10. Montagnino G, Colturi C, Banfi G, Aroldi A, Tarantino A, Ponticelli C: Membranous nephropathy in cyclosporinetreated renal transplant recipients. Transplantation 47: 725-727, 1989 (Pubitemid 19110938)
11. Odorico JS, Knechtle SJ, Rayhill SC, Pirsch JD, D'Alessandro AM, Belzer FO, Sollinger HW: The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 61: 228-234, 1996
12. Obermiller LE, Hoy WE, Eversole M, Sterling WA: Recurrent membranous glomerulonephritis in two renal transplants. Transplantation 40: 100-102, 1985 (Pubitemid 15006770)
13. Josephson MA, Spargo B, Hollandsworth D, Thistlethwaite JR: The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: Case report and literature review. Am J Kidney Dis 24: 873-878, 1994 (Pubitemid 24350478)
14. Dabade TS, Grande JP, Norby SM, Fervenza FC, Cosio FG: Recurrent idiopathic membranous nephropathy after kidney transplantation: A surveillance biopsy study. Am J Transplant 8: 1318-1322, 2008
15. Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M, Perna A, Filippi C, Remuzzi G: Rituximab in idiopathic membranous nephropathy: A one-year prospective study. J Am Soc Nephrol 14: 1851-1857, 2003
16. Ruggenenti P, Cravedi P, Sghirlanzoni MC, Gagliardini E, Conti S, Gaspari F, Marchetti G, Abbate M, Remuzzi G: Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy. Clin J Am Soc Nephrol 3: 1652-1659, 2008
17. Churg J, Ehrenreich T: Membranous nephropathy. Perspect Nephrol Hypertens 1: 443-448, 1973
18. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
19. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V: Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry (RADR). Transplantation 68: 635-641, 1999 (Pubitemid 29453439)
20. Cosyns JP, Pirson Y, Squifflet JP, Alexandre GP, van Ypersele de Strihou C, Pinn VW, Sweet SJ, Shapiro KS, Cho S, Harrington JT: De novo membranous nephropathy in human renal allografts: Report of nine patients. Kidney Int 22: 177-183, 1982 (Pubitemid 12061652)
21. Gallon L, Chhabra D: Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient. Am J Transplant 6: 3017-3021, 2006
22. Weclawiak H, Ribes D, Guilbeau-Frugier C, Touchard G, Kamar N, Mehrenberger M, Modesto A, Rostaing L: Relapse of membranous glomerulopathy after kidney transplantation: Sustained remittance induced by rituximab. Clin Nephrol 69: 373-376, 2008
23. Sirimongkolrat T, Premasathian N, Vongwiwatana A, Limsrichamrern S, Cheunsuchon B, Vasuvattakul S: Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: A case report. Transplant Proc 40: 2440-2441, 2008